Canine Orthopedics Market- Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Product (Implants, Instruments), By Application (TPLO, TTA, Joint Replacement, Trauma, Others), By End-use (Hospitals & Clinics, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 262.53 Million
CAGR (2026-2031)	8.77%
Fastest Growing Segment	Implants
Largest Market	North America
Market Size (2031)	USD 434.74 Million

Market Overview

The Global Canine Orthopedics Market will grow from USD 262.53 Million in 2025 to USD 434.74 Million by 2031 at a 8.77% CAGR. The Global Canine Orthopedics Market consists of the manufacturing and supply of medical implants, instruments, and supportive devices designed to treat musculoskeletal injuries and degenerative conditions in dogs. A primary driver fueling this sector is the consistent rise in pet ownership coupled with the humanization of companion animals, which motivates owners to seek advanced medical interventions for issues such as osteoarthritis and cruciate ligament ruptures. According to the American Veterinary Medical Association, in 2024, the estimated dog population in the United States reached 89.7 million. This expanding patient base directly supports the demand for specialized veterinary orthopedic services and products.

Despite these positive indicators, a significant challenge impeding broader market expansion is the high cost associated with complex orthopedic surgeries. Procedures such as total hip replacements and fracture repairs involve expensive materials and require highly skilled veterinary specialists, resulting in substantial financial burdens for pet owners. This affordability gap often limits access to premium care for uninsured pets and restricts market penetration in developing regions where veterinary healthcare infrastructure is less established and disposable income is lower.

Key Market Drivers

The rising incidence of canine musculoskeletal disorders and obesity acts as a primary catalyst for market growth, creating sustained demand for orthopedic interventions. Excess weight in dogs significantly accelerates joint degradation, leading to higher prevalence rates of osteoarthritis and cruciate ligament injuries that require surgical repair or long-term management with implants. This link between weight and orthopedic health is becoming increasingly evident in clinical data. According to the Association for Pet Obesity Prevention, April 2025, in the '2024 Pet Obesity & Nutrition Opinion Survey', 35% of dog owners classified their pets as overweight or having obesity, a marked increase from 17% in the previous year. This surge in the at-risk population directly necessitates a broader application of orthopedic solutions, from diagnostic instruments to advanced surgical implants, as veterinarians address the physical toll of weight-related comorbidities.

Concurrently, the increasing adoption of pet health insurance policies is mitigating the financial barriers associated with expensive orthopedic procedures, thereby expanding patient access to premium care. As insurance coverage becomes more widespread, pet owners are more likely to approve costly treatments such as total hip replacements or fracture repairs, which might otherwise be unaffordable. According to the North American Pet Health Insurance Association, April 2025, in the '2025 State of the Industry Report', the total premium volume for pet insurance in the United States reached approximately $4.7 billion at year-end 2024. This financial buffer is critical given the rising costs of veterinary medicine; for instance, according to Synchrony, in 2025, the estimated lifetime cost of caring for a dog has risen to between $22,125 and $60,602. Consequently, the insurance sector serves as a vital enabler for the canine orthopedics market, converting potential demand into actualized surgical revenue.

Download Free Sample Report

Key Market Challenges

The high cost associated with complex orthopedic surgeries constitutes a substantial barrier to the growth of the Global Canine Orthopedics Market. Procedures such as total hip replacements and cruciate ligament repairs necessitate expensive medical-grade implants and the expertise of specialized veterinary surgeons. Consequently, the price of these interventions often exceeds the disposable income of many pet owners, leading them to opt for conservative, non-surgical management or, in severe cases, economic euthanasia. This economic constraint directly reduces the volume of implants and instruments utilized, thereby stalling market revenue potential and limiting the adoption of advanced technologies.

Furthermore, the market is heavily reliant on out-of-pocket payments due to the limited prevalence of pet health insurance. The lack of financial safety nets exacerbates the affordability gap, particularly when owners are faced with sudden, large-scale medical expenses. According to the North American Pet Health Insurance Association, in 2024, the total number of insured pets in North America reached 7.03 million. This figure indicates that the vast majority of the pet population remains uninsured, leaving most owners solely responsible for the substantial financial burden of premium orthopedic care and significantly narrowing the addressable market for surgical solutions.

Key Market Trends

The Integration of Regenerative Medicine Therapies with Orthopedic Procedures is shifting the market focus from symptom management to biological restoration. Veterinary surgeons are increasingly utilizing stem cell therapies and platelet-rich plasma in conjunction with surgical interventions to accelerate tissue healing and mitigate osteoarthritis progression. This approach is gaining commercial viability as biotechnology firms secure substantial investment to develop standardized, off-the-shelf biological products. According to Gallant Therapeutics, June 2025, in the 'Gallant Closes $18 Million Series B to Bring Ready-to-Use Stem Cell Therapies for Pets to Market' press release, the company raised $18 million to advance the conditional FDA approval of its allogeneic stem cell pipeline. This capital highlights the transition towards scalable therapeutics that address the underlying pathology of joint degeneration rather than merely masking pain.

Simultaneously, the Expansion of Specialized Post-Operative Physical Rehabilitation Modalities is establishing structured recovery protocols as a critical component of orthopedic care. The veterinary community now recognizes that surgical outcomes improve significantly when paired with professional rehabilitation, driving demand for sports medicine specialists and targeted recovery programs. This evolution is supported by increased funding for clinical research designed to refine rehabilitation techniques for canine athletes. According to the American Kennel Club Canine Health Foundation, August 2025, in the '2024 Impact Report', the organization strategically invested $3.2 million across 42 research grants, including specific support for sports medicine and rehabilitation residency programs. These initiatives are essential for validating evidence-based strategies, ensuring that complex orthopedic repairs result in optimal long-term functional mobility.

Segmental Insights

According to industry intelligence, the Implants segment represents the fastest-growing category within the Global Canine Orthopedics Market. This expansion is largely driven by the rising prevalence of orthopedic conditions, such as cranial cruciate ligament ruptures and hip dysplasia, which compel the use of internal fixation devices. Furthermore, continuous improvements in biomaterials have led to the development of highly durable plates and screws that facilitate superior recovery. As pet owners increasingly elect for restorative surgeries supported by pet insurance, the adoption of these essential medical devices continues to surge globally.

Regional Insights

North America holds a dominant position in the global canine orthopedics market, primarily driven by high pet ownership rates and significant expenditure on veterinary healthcare. The region benefits from a well-established infrastructure for animal health and the strong presence of key industry manufacturers. Additionally, the widespread availability of pet medical insurance encourages owners to opt for necessary orthopedic procedures. This market stability is further supported by clear regulatory pathways established by the U.S. FDA Center for Veterinary Medicine, which facilitates the approval of essential veterinary medical devices and treatments.

Recent Developments

• In July 2025, Movora entered into an exclusive distribution agreement with Aesculap, a division of B. Braun, to supply surgical power tools to the North American veterinary market. Under this partnership, Movora became the sole distributor of Aesculap’s motor systems, which are widely used in veterinary orthopedic and neurosurgical procedures for sawing and drilling. The collaboration combines Aesculap’s renown for high-quality surgical equipment with Movora’s extensive sales network and educational platforms. This strategic move aims to broaden the availability of premium surgical power solutions to veterinary professionals specializing in orthopedics across the region.
• In October 2024, VCA Animal Hospitals inaugurated a dedicated 3D printing laboratory at its specialist facility in Oregon to advance the capabilities of veterinary orthopedic surgery. The new lab utilizes advanced 3D printing technology to design and fabricate custom-fitted implants and patient-specific surgical guides based on CT scan data. This innovation allows surgeons to treat complex orthopedic conditions, such as angular limb deformities and joint dysplasia, with greater precision and personalization. The initiative represents a significant investment by the veterinary network to integrate digital design and additive manufacturing directly into clinical practice for improved patient recovery.
• In June 2024, Arthrex Vet Systems expanded its fracture management portfolio with the release of the OrthoLine Distal Humeral Fracture System. This new offering was designed to provide veterinary surgeons with a comprehensive plating solution specifically engineered for complex fractures of the distal humerus in dogs. The system features a low-profile plate design to minimize soft tissue irritation and includes variable-angle locking screw technology to enhance construct stability. This product launch underscores the company's commitment to developing specialized instruments and implants that improve surgical reproducibility and outcomes in small animal orthopedics.
• In January 2024, TheraVet announced the commercial expansion of its flagship product line into the German veterinary market. The biotechnology company, which specializes in the management of osteoarticular diseases in companion animals, introduced its bone substitute range, BIOCERA-VET, to veterinarians in Germany. This product portfolio includes solutions for bone surgery, such as fracture management and arthrodesis, as well as a palliative treatment for canine osteosarcoma. The launch was supported by the company's participation in a major veterinary congress in Leipzig, aiming to address the needs of the robust German pet care sector.

Key Market Players

• B. Braun SE
• Movora
• Steris Plc
• Johnson & Johnson Services, Inc.
• Cencora, Inc.
• Arthrex, Inc.
• Orthomed (UK) Ltd
• Veterinary Instrumentation Ltd
• Fusion Implants
• Narang Medical Limited

By Product	By Application	By End-use	By Region
Implants Instruments	TPLO TTA Joint Replacement Trauma Others	Hospitals & Clinics Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Canine Orthopedics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Canine Orthopedics Market, By Product:

• Implants
• Instruments

• Canine Orthopedics Market, By Application:

• TPLO
• TTA
• Joint Replacement
• Trauma
• Others

• Canine Orthopedics Market, By End-use:

• Hospitals & Clinics
• Others

• Canine Orthopedics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE